Solid Organ Transplant Segment to Dominate the Organ Transplant Diagnostics Market (by Transplant Type) The solid organ transplant segment is expected to dominate the organ transplant diagnostics ...

Oncocyte is at a pivotal stage in commercializing what we expect to be an industry-transforming organ transplant rejection monitoring test. We aim to deliver proven, more affordable, faster tests that ...

Major discrepancies are seen with the use of noninvasive tests compared with liver biopsy in a posttransplant setting.

On average when positive, Signatera tests have a 98%-99% rate of accurately predicting the presence of cancer depending on the cancer, and the false-positive rate is less than 2% to 1% depending on ...

An official cause of death for actor Michelle Trachtenberg — best known for her roles in “Harriet the Spy,” “Gossip Girl,” ...

Scientists have grown a tooth in a lab, marking a significant step toward regenerative dental treatments. The study, carried ...

KYOTO—Kyoto University Hospital officials announced on April 14 that a research team conducted a clinical trial in February to transplant lab-grown pancreatic islets into a woman in her 40s who has ...

These statements include those pertaining to, among other things, Oncocyte’s progress toward commercializing a regulated organ transplant rejection monitoring test kit ... or potential failure to ...

In another example of TAM expansion, we published data showing that our assay can detect organ rejection in transplant patients 11 months ahead of standard protocols in certain high-risk populations.

That study used our assay to monitor response to felzartamab for patients at risk for kidney transplant rejection ... our Nashville lab by performing studies and testing instruments for paying ...

Crossmatch tests of the prospective kidney ... antibodies may develop as a result of homograft rejection and may be detected especially after transplant nephrectomy. 7 On this basis, immediate ...